Patent Baristas

In an Op-Ed piece in the New York Times entitled “Patently Ridiculous,” the editors state that “something has gone very wrong with the United States patent system. That’s not really “new” as far as patent reform claims of this sort go but the editors do finally concede that the problem lies “not just with the […]

In Rockey, Inc. v. Cordis Corp. (05-1236), the U.S. Court of Appeals for the Federal Circuit held that determining patent infringement is a two-step process consisting of the court construing the claims and then comparing the allegedly infringing device to the properly construed claims. Arlaine & Gina Rockey, Inc. (“AGR”) filed an action against Cordis […]

TechnoScore: 4.8 (Rated by 4 Users) Introduction SmartDraw.com’s SmartDraw Legal Solution enables legal professionals without any design expertise to create professional-looking graphics to persuade clients, judges, juries and even opposing counsel. The SmartDraw Legal Solution includes more than 1,000 templates and 50,000 images for accident reconstructions, crime scenes, maps, medical diagrams, Gantt charts, organizational charts, […]

The biggest invention news this week has not been American Inventor but an update to the way patent applications are filed. While we’ve been participating in the beta testing program for months now, the United States Patent and Trademark Office’s (USPTO) has officially released the new electronic filing system (EFS-Web) that will allow applicants to […]

The Food and Drug Administration (FDA) released an initial list of priority research projects that could advance innovation in medical products. The announcement of the Critical Path Opportunities List signals the next major step in FDA’s Critical Path Initiative aimed at modernizing medical product development, so new medical discoveries are brought to patients faster and […]

The European Medicines Agency (EMEA) published a set of five final guidelines on similar biological medicinal products. They are intended to give guidance to industry in the development of this new type of applications for marketing authorisation. They give guidance on quality, non-clinical and clinical issues. The product class specific annexes to the guideline on […]

As the hosts the 48th Edition of Blawg Review with “unfettered discretion,” the Rethink(ip) guys hate carnivals. At least the ones they have become, in their words, “bloated, link-whore-optimized versions of the original vision for what a carnival should be – an edited review of relevant blog posts presented in a manner that contributes to […]

Recently, I had a client that was about to license a biotech invention for development as a therapeutic. In the course of discussions, we found that in order to bring the product to market, the licensee may need to obtain rights from various other rights holders. As a result, the licensee may be faced with […]